Literature DB >> 3463269

The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome.

R D Gordon.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3463269     DOI： 10.1111/j.1445-5994.1986.tb01145.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  10 in total

1.  γ-Adducin stimulates the thiazide-sensitive NaCl cotransporter.

Authors:  Henrik Dimke; Pedro San-Cristobal; Mark de Graaf; Jacques W Lenders; Jaap Deinum; Joost G J Hoenderop; René J M Bindels
Journal:  J Am Soc Nephrol       Date:  2010-12-16       Impact factor: 10.121

2.  WNK1 activates SGK1 to regulate the epithelial sodium channel.

Authors:  Bing-e Xu; Steve Stippec; Po-Yin Chu; Ahmed Lazrak; Xin-Ji Li; Byung-Hoon Lee; Jessie M English; Bernardo Ortega; Chou-Long Huang; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

Review 3.  Aldosterone blockade in chronic kidney disease: can it improve outcome?

Authors:  Robert D Toto
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

Review 4.  Exploring the intricate regulatory network controlling the thiazide-sensitive NaCl cotransporter (NCC).

Authors:  Henrik Dimke
Journal:  Pflugers Arch       Date:  2011-09-17       Impact factor: 3.657

5.  WNK4 is the major WNK positively regulating NCC in the mouse kidney.

Authors:  Daiei Takahashi; Takayasu Mori; Naohiro Nomura; Muhammad Zakir Hossain Khan; Yuya Araki; Moko Zeniya; Eisei Sohara; Tatemitsu Rai; Sei Sasaki; Shinichi Uchida
Journal:  Biosci Rep       Date:  2014-05-09       Impact factor: 3.840

6.  WNK4 is an Adipogenic Factor and Its Deletion Reduces Diet-Induced Obesity in Mice.

Authors:  Daiei Takahashi; Takayasu Mori; Eisei Sohara; Miyako Tanaka; Motoko Chiga; Yuichi Inoue; Naohiro Nomura; Moko Zeniya; Hiroki Ochi; Shu Takeda; Takayoshi Suganami; Tatemitsu Rai; Shinichi Uchida
Journal:  EBioMedicine       Date:  2017-03-08       Impact factor: 8.143

7.  Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).

Authors:  Mark Glover; James S Ware; Amanda Henry; Martin Wolley; Roddy Walsh; Louise V Wain; Shengxin Xu; William G Van't Hoff; Martin D Tobin; Ian P Hall; Stuart Cook; Richard D Gordon; Michael Stowasser; Kevin M O'Shaughnessy
Journal:  Clin Sci (Lond)       Date:  2014-05       Impact factor: 6.124

8.  Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene.

Authors:  Yuya Araki; Tatemitsu Rai; Eisei Sohara; Takayasu Mori; Yuichi Inoue; Kiyoshi Isobe; Eriko Kikuchi; Akihito Ohta; Sei Sasaki; Shinichi Uchida
Journal:  Biol Open       Date:  2015-10-21       Impact factor: 2.422

9.  WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4.

Authors:  Shintaro Mandai; Takayasu Mori; Naohiro Nomura; Taisuke Furusho; Yohei Arai; Hiroaki Kikuchi; Emi Sasaki; Eisei Sohara; Tatemitsu Rai; Shinichi Uchida
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

Review 10.  The Molecular Genetics of Gordon Syndrome.

Authors:  Holly Mabillard; John A Sayer
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.